1. Home
  2. XBP vs ACXP Comparison

XBP vs ACXP Comparison

Compare XBP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

N/A

Current Price

$2.90

Market Cap

33.1M

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.40

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
ACXP
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.1M
6.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
XBP
ACXP
Price
$2.90
$1.40
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$95.50
AVG Volume (30 Days)
15.7K
176.5K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
183.67
N/A
EPS
N/A
N/A
Revenue
$872,690,000.00
N/A
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.31
52 Week High
$8.55
$8.34

Technical Indicators

Market Signals
Indicator
XBP
ACXP
Relative Strength Index (RSI) 50.37 44.16
Support Level $2.82 $1.34
Resistance Level $3.09 $1.75
Average True Range (ATR) 0.27 0.05
MACD -0.01 -0.00
Stochastic Oscillator 71.20 6.67

Price Performance

Historical Comparison
XBP
ACXP

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: